Letters to the Editor

Utility of the Central Nervous System International Prognostic Index in patients with primary mediastinal large B-cell lymphoma treated with rituximab-containing chemoimmunotherapy

Division of Medical Oncology, University of British Columbia, Vancouver, BC
Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada; Center for Lymphoid Cancer, BC Cancer, Vancouver, BC
Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada; Center for Lymphoid Cancer, BC Cancer, Vancouver, BC
Center for Lymphoid Cancer, BC Cancer, Vancouver, BC
Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada; Center for Lymphoid Cancer, BC Cancer, Vancouver, BC
Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada; Center for Lymphoid Cancer, BC Cancer, Vancouver, BC
Center for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada; Division of Pathology, University of British Columbia, Vancouver, BC
Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada; Center for Lymphoid Cancer, BC Cancer, Vancouver, BC
Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada; Center for Lymphoid Cancer, BC Cancer, Vancouver, BC
Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada; Center for Lymphoid Cancer, BC Cancer, Vancouver, BC
Haematologica Early view Oct 2, 2025 https://doi.org/10.3324/haematol.2025.288699